Overview

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

Status:
Unknown status
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of 18-22mg/kg/d Ursodeoxycholic in refractory Primary Biliary Cholangitis
Phase:
Phase 4
Details
Lead Sponsor:
West China Hospital